Evidence map›Paper›PMID 37398543›Full record

ArticleJournal of orthopaedic case reports2023

Diffuse Tenosynovial Giant Cell Tumor Encircling the First Metatarsal Bone Remodeling after Resection. A Case Report.

Panagiotis D Symeonidis, Maria Tsatlidou, Ioannis Spanos, Maria Papageorgiou, Georgios Kesisis, Katerina Zarampouka

Abstract readCase Reports
In one paragraph

Article in Journal of orthopaedic case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Panagiotis D SymeonidisDepartment of Orthopaedic, St Luke's Hospital, Panorama, Thessaloniki, Greece, Thessaloniki, Greece.
Maria TsatlidouDepartment of Orthopaedic, St Luke's Hospital, Panorama, Thessaloniki, Greece, Thessaloniki, Greece.
Ioannis SpanosDepartment of Orthopaedic, St Luke's Hospital, Panorama, Thessaloniki, Greece, Thessaloniki, Greece.
Maria PapageorgiouBioiatriki S.A., Diagnostic Center, Thessaloniki, Greece.
Georgios KesisisDepartment of Orthopaedic, St Luke's Hospital, Panorama, Thessaloniki, Greece, Thessaloniki, Greece.
Katerina ZarampoukaDepartment of Pathology, Medical School of Aristotle University of Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The term tenosynovial giant cell tumor encompasses a group of rare soft-tissue tumors. A new classification divides the group in localized and diffuse type, depending on the involvement of the surrounding tissues. Due to the unclear origin and heterogeneity in extend of the diffuse-type giant cell tumors, there is only limited evidence on the tumor-specific treatment. Thus, every case report has an added value toward setting disease-specific guidelines. Case Report: Presentation of a diffuse type tenosynovial giant cell tumor encircling the first metatarsal. The tumor had mechanically eroded the plantar aspect of the distal metaphysis, with no signs of tumor spread. After an open biopsy, resection of the mass was performed without debriding or resecting the first metatarsal. Repeat imaging postoperatively showed no recurrence at 4-year follow-up and a bony remodeling of the lesion. Conclusion: Bone remodeling is possible after complete resection of diffuse tenosynovial giant cell tumor when the erosion is caused by mechanical pressure and no intraosseous expansion of the tumor is present.

Indexed as

bone remodelingbony erosionDiffuse-type tenosynovial giant cell tumorfirst metatarsal

Identifiers

PMID37398543
PMCPMC10308984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.